Serial MRD results. MRD data were obtained for 29 of 30 patients at the end of induction I (combination treatment) and 28 of 30 patients at the end induction II (venetoclax monotherapy), cycle 8 and cycle 14, respectively. Additional MRD data were obtained for 18 of 30 patients at 3 months after randomization. (A) Absolute numbers of measured MRD on peripheral blood. (B) Kinetics of MRD per patient.